# Project Summary
The MIND-USA clinical trial aims to define the role of antipsychotics in the management of delirium in critically ill patients, specifically comparing haloperidol *(typical antipsychotic)* and ziprasidone *(atypical antipsychotic)* to placebo.
The manuscript was posted in the *New England Journal of Medicine* online in October 2018 ([doi: 10.1056/NEJMoa1808217](https://doi.org/10.1056/NEJMoa1808217)). The full statistical analysis report can be found [here on OSF](https://osf.io/sqa6m/). Historical details on this project can be found in this project or in the trial listing on [clinicaltrials.gov](https://clinicaltrials.gov/ct2/show/NCT01211522).